Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Chemoradiation in Stage III NSCLC
NCT00547443Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by UT Southwestern Medical Center. Planned start Jul 2007; status: withdrawn.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00547443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547443.